Dosimetric comparison between I-125 seed implantation and stereotactic body radiotherapy (SBRT) in patients with hepatic malignancies
Brachytherapy · 2025
DOI: 10.1016/j.brachy.2025.06.002 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Brachytherapy, 2025. Verfasst von Xu Zhu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Ansteel Group Hospital, Anshan, Liaoning, China. Hauptthemen laut MEDLINE: Radiosurgery, Liver Neoplasms, Iodine Radioisotopes, Brachytherapy. Die Arbeit nennt 28 Literaturangaben. Gefördert von: Liaoning Provincial Natural Science Foundation.
Abstract (Originalsprache)
PURPOSE: This study aims to compare the dosimetric values of I-125 seed implantation with stereotactic body radiotherapy (SBRT) in the treatment of hepatic cancer patients. METHODS AND MATERIALS: The study retrospectively analyzed 23 patients with hepatic malignancies treated with SBRT. A virtual I-125 seed implantation plan was simulated for comparison. For I-125 seed implantation, a prescription dose of 110 Gy was delivered to the gross tumor volume (GTV), corresponding to the planned target volume (PTV) in SBRT. Dosimetric values, including target coverage and dose to organs at risk (OARs), were compared using paired t-tests. RESULTS AND CONCLUSIONS: The average PTV volume receiving 100% of the prescription dose was similar between the I-125 and SBRT groups (86.0% vs. 78.7%, p = 0.172). The I-125 group mean PTV V150% 62.9% ± 8.5%, while SBRT plans inherently restrict maximum PTV doses to ≤150% (resulting in 0% V150%). The mean minimum dose to PTV was significantly greater in the I-125 group than in the SBRT group (5562.49 cGy vs. 3289.69 cGy, p < 0.01). Regarding OARs, the liver volume receiving ≥15 Gy was significantly lower in the I-125 group (274.67 cc vs. 485.72 cc, p < 0.01), with similar trends observed for the small intestine, kidneys, stomach, and colon. Dosimetric analysis revealed differences in dose distribution within the target volume and efficient OARs sparing using I-125 seed implantation compared with SBRT. Additional studies are required to examine the clinical relevance of these findings and determine whether combining these two methods may offer higher therapeutic benefit.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, Ansteel Group Hospital, Anshan, Liaoning, China.
- Department of Neurosurgery, The First Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning, China. Electronic address: zhb100b@163.com.
- Department of Radiation Oncology, Ansteel Group Hospital, Anshan, Liaoning, China. Electronic address: dengbinwuu@outlook.com.
Förderung
- Liaoning Provincial Natural Science Foundation
Zitieren
APA
Zhu, X., Zhang, B., Kong, Q., Li, Y., Fan, P., & Wu, D. (2025). Dosimetric comparison between I-125 seed implantation and stereotactic body radiotherapy (SBRT) in patients with hepatic malignancies. Brachytherapy. https://doi.org/10.1016/j.brachy.2025.06.002
Vancouver
Zhu X, Zhang B, Kong Q, Li Y, Fan P, Wu D. Dosimetric comparison between I-125 seed implantation and stereotactic body radiotherapy (SBRT) in patients with hepatic malignancies. Brachytherapy. 2025. doi:10.1016/j.brachy.2025.06.002
BibTeX
@article{Zhu2025,
author = {Zhu, Xu and Zhang, Bo and Kong, Qi and Li, Yuheng and Fan, Pengfei and Wu, Dengbin},
title = {Dosimetric comparison between I-125 seed implantation and stereotactic body radiotherapy (SBRT) in patients with hepatic malignancies},
journal = {Brachytherapy},
year = {2025},
doi = {10.1016/j.brachy.2025.06.002}
}
EUVIMED